Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Spectrum Pharma Inc (SPPI)

Spectrum Pharma Inc (SPPI)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
SmarTrend Watching for Potential Pullback in Shares of Spectrum Pharmac After 1.74% Gain

Spectrum Pharmac (NASDAQ:SPPI) traded in a range yesterday that spanned from a low of $4.32 to a high of $4.46. Yesterday, the shares gained 1.7%, which took the trading range above the 3-day high of...

SPPI : 4.71 (-0.42%)
Spectrum Pharmaceuticals to Present at Two Upcoming Investor Conferences in November

Spectrum Pharmaceuticals (NasdaqGS: SPPI), a biopharmaceutical company focused on novel and targeted oncology therapies, announced today that management will present an overview of the company's business...

SPPI : 4.71 (-0.42%)
Spectrum Pharmaceuticals (SPPI) Reports Q3 Loss, Misses Revenue Estimates

Spectrum Pharma (SPPI) delivered earnings and revenue surprises of 0.00% and -100.00%, respectively, for the quarter ended September 2020. Do the numbers hold clues to what lies ahead for the stock?

SPPI : 4.71 (-0.42%)
Spectrum Pharma: 3Q Earnings Snapshot

HENDERSON, Nev. (AP) _ Spectrum Pharmaceuticals Inc. (SPPI) on Wednesday reported a loss of $48.5 million in its third quarter.

SPPI : 4.71 (-0.42%)
Spectrum Pharmaceuticals, Inc. to Host Earnings Call

NEW YORK, NY / ACCESSWIRE / November 4, 2020 / Spectrum Pharmaceuticals, Inc. (SPPI) (NASDAQ:SPPI) will be discussing their earnings results in their call to be held on November 4, 2020 at 4:30 PM Eastern...

SPPI : 4.71 (-0.42%)
Spectrum Pharmaceuticals Reports Third Quarter 2020 Financial Results and Corporate Update

--Pre-NDA meeting with FDA is scheduled for poziotinib in NSCLC HER2 exon-20 insertion mutations in previously treated patients

SPPI : 4.71 (-0.42%)
Spectrum Pharmaceuticals to Report Third Quarter 2020 Financial Results and Provide Corporate Update

Spectrum Pharmaceuticals (NasdaqGS: SPPI) a biopharmaceutical company focused on novel and targeted oncology therapies, today announced it will host a conference call to discuss the third quarter 2020...

SPPI : 4.71 (-0.42%)
Spectrum Pharmaceuticals Announces that the FDA is Deferring its Action on the BLA for ROLONTIS(R) (eflapegrastim)

Spectrum Pharmaceuticals (NasdaqGS: SPPI), a biopharmaceutical company focused on novel and targeted oncology therapies, today announced that an inspection of the Hanmi Bioplant in South Korea is required...

SPPI : 4.71 (-0.42%)
Spectrum Pharmaceuticals (SPPI) Jumps: Stock Rises 7%

Spectrum Pharmaceuticals (SPPI) saw a big move last session, as its shares jumped 7% on the day, amid huge volumes.

SPPI : 4.71 (-0.42%)
CTLT : 96.47 (-0.95%)
Spectrum Pharmaceuticals Presents Results in HER2 Exon 20 Insertion Mutations from Cohort 2 of the Poziotinib ZENITH20 Clinical Trial

Spectrum Pharmaceuticals (NasdaqGS: SPPI), a biopharmaceutical company focused on novel and targeted oncology therapies, today presented additional results from its pivotal Phase 2 clinical trial, ZENITH20,...

SPPI : 4.71 (-0.42%)
Implied Volatility Surging for Spectrum (SPPI) Stock Options

Investors need to pay close attention to Spectrum (SPPI) stock based on the movements in the options market lately.

SPPI : 4.71 (-0.42%)
Spectrum Pharmaceuticals Announces Two Presentations for Poziotinib at ESMO Virtual Congress 2020

Spectrum Pharmaceuticals (NasdaqGS: SPPI), a biopharmaceutical company focused on novel and targeted oncology therapies, today announced a presentation of the results for Cohort 2 from its Phase 2 clinical...

SPPI : 4.71 (-0.42%)
Spectrum Pharmaceuticals to Present at Two Upcoming Investor Conferences in September

Spectrum Pharmaceuticals (NasdaqGS: SPPI), a biopharmaceutical company focused on novel and targeted oncology therapies, announced today that management will present an overview of the company's business...

SPPI : 4.71 (-0.42%)
Spectrum Pharmaceuticals (SPPI) Reports Q2 Loss, Lags Revenue Estimates

Spectrum Pharma (SPPI) delivered earnings and revenue surprises of 12.12% and -100.00%, respectively, for the quarter ended June 2020. Do the numbers hold clues to what lies ahead for the stock?

SPPI : 4.71 (-0.42%)
Spectrum Pharma: 2Q Earnings Snapshot

HENDERSON, Nev. (AP) _ Spectrum Pharmaceuticals Inc. (SPPI) on Monday reported a loss of $32.1 million in its second quarter.

SPPI : 4.71 (-0.42%)
Spectrum Pharmaceuticals Reports Second Quarter 2020 Financial Results and Corporate Update

--Company is in process of requesting a pre-NDA meeting with the FDA seeking an indication for second-line NSCLC patients with HER2 exon 20 insertion mutations

SPPI : 4.71 (-0.42%)
Spectrum Pharmaceuticals Announces Full Exercise of Underwriters' Option to Purchase Additional Shares

Spectrum Pharmaceuticals, Inc. (Nasdaq: SPPI) ("Spectrum" or the "Company"), a biopharmaceutical company focused on novel and targeted oncology therapies, today announced that the underwriters of its previously...

SPPI : 4.71 (-0.42%)
Spectrum Pharmaceuticals to Report Second Quarter 2020 Financial Results and Provide Corporate Update

Spectrum Pharmaceuticals (NasdaqGS: SPPI) a biopharmaceutical company focused on novel and targeted oncology therapies, today announced it will host a conference call to discuss the second quarter 2020...

SPPI : 4.71 (-0.42%)
Spectrum Pharmaceuticals Presents Same Day Dosing Data for ROLONTIS(R) (eflapegrastim) at AACR Virtual Annual Meeting II

Spectrum Pharmaceuticals, Inc. (NASDAQ-GS: SPPI), a biopharmaceutical company focused on novel and targeted oncology therapies, today announced preclinical data evaluating the administration of ROLONTIS(R)...

SPPI : 4.71 (-0.42%)
Spectrum Pharmac Set to Possibly Pullback After Yesterday's Rally of 3.40%

Spectrum Pharmac (NASDAQ:SPPI) traded in a range yesterday that spanned from a low of $2.90 to a high of $3.05. Yesterday, the shares gained 3.4%, which took the trading range above the 3-day high of...

SPPI : 4.71 (-0.42%)

Van Meerten Stock Picks

5 Great Small Caps
Summary 100% technical buy signals.
Jim Van Meerten uses Barchart's tools to offer daily stock picks and recommendations. His portfolios have been honored by Marketocracy and Morningstar.

InsideFutures Commentary

InsideFutures is a twice weekly newsletter that features a selection of the latest and best commodities commentary appearing on Barchart.com. Delivered every Wednesday and Friday morning to your inbox.

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar